Last reviewed · How we verify
Segmental allergen challenge
Segmental allergen challenge is a Biologic drug developed by JOSALYN CHO. It is currently in Phase 2 development.
At a glance
| Generic name | Segmental allergen challenge |
|---|---|
| Sponsor | JOSALYN CHO |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation (PHASE1)
- Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma (NA)
- Airway Immune Response to Allergens (Use Lay Language Here) (PHASE1)
- Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics (PHASE2)
- AsthMatic Inflammation and Neurocircuitry Activation (MINA)
- Airway Temperature (PHASE1)
- Functional Activity of Airway Eosinophils in Allergic Disease
- Analysis of Fel d 1-specific T Cells After Airway Allergen Challenge in Asthma
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Segmental allergen challenge CI brief — competitive landscape report
- Segmental allergen challenge updates RSS · CI watch RSS
- JOSALYN CHO portfolio CI
Frequently asked questions about Segmental allergen challenge
What is Segmental allergen challenge?
Segmental allergen challenge is a Biologic drug developed by JOSALYN CHO.
Who makes Segmental allergen challenge?
Segmental allergen challenge is developed by JOSALYN CHO (see full JOSALYN CHO pipeline at /company/josalyn-cho).
What development phase is Segmental allergen challenge in?
Segmental allergen challenge is in Phase 2.
Related
- Manufacturer: JOSALYN CHO — full pipeline
- Compare: Segmental allergen challenge vs similar drugs
- Pricing: Segmental allergen challenge cost, discount & access